NASDAQ:MGX Metagenomi Q2 2026 Earnings Report $1.12 +0.02 (+1.82%) As of 04:00 PM Eastern ProfileEarnings HistoryForecast Metagenomi EPS ResultsActual EPS-$0.73Consensus EPS -$0.55Beat/MissMissed by -$0.18One Year Ago EPSN/AMetagenomi Revenue ResultsActual Revenue($0.26) millionExpected Revenue$3.01 millionBeat/MissMissed by -$3.27 millionYoY Revenue GrowthN/AMetagenomi Announcement DetailsQuarterQ2 2026Date8/10/2026TimeAfter Market ClosesConference Call DateMonday, August 10, 2026Conference Call Time7:00AM ETUpcoming EarningsMetagenomi's Q3 2026 earnings is estimated for Tuesday, November 10, 2026, based on past reporting schedules, with a conference call scheduled at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Conference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Metagenomi Earnings HeadlinesMetagenomi Therapeutics, Inc. to Present at the Wells Fargo 21st Annual Healthcare ConferenceSeptember 1, 2026 | globenewswire.comMetagenomi Therapeutics Inc MGXAugust 25, 2026 | morningstar.comMLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.September 21 at 1:00 AM | InvestorPlace (Ad)Did Metagenomi Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders?August 25, 2026 | prnewswire.comMGX Resources Limited (MTGRY) Q4 2026 Earnings Call Prepared Remarks TranscriptAugust 20, 2026 | seekingalpha.comAnalysts’ Top Healthcare Picks: Metagenomi, Inc. (MGX), Kymera Therapeutics (KYMR)August 11, 2026 | theglobeandmail.comSee More Metagenomi Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Metagenomi? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Metagenomi and other key companies, straight to your email. Email Address About MetagenomiMetagenomi (NASDAQ:MGX) is a biotechnology company developing genetic medicines using genome-editing technologies discovered through metagenomic research. The company searches genetic material from diverse microorganisms to identify naturally occurring editing systems and combines these discoveries with machine-learning tools to develop potential therapies. Its research platform is designed to support the development of genome-editing medicines for a range of diseases, including programs intended to make precise changes to DNA in human cells. Metagenomi’s product candidates and discovery efforts have focused on both in vivo and ex vivo applications, although the status and scope of individual programs may change as the company advances its research pipeline. Founded in 2018, Metagenomi is headquartered in Emeryville, California, and has pursued collaborations and strategic relationships with larger life-sciences companies to support the development and potential commercialization of its technologies. The company was co-founded by Brian C. Thomas, Ph.D., who has served as its chief executive officer. Metagenomi began trading publicly on the Nasdaq under the symbol MGX in 2024.View Metagenomi ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles 5 Dividend Stocks That Combine Income, Earnings Growth, and Wall Street SupportCoach’s Momentum Powers Tapestry Despite the Stock’s Sharp Pullback3 Retail Stocks Getting Crushed and the Long-Dated Options Trade on Each One3 Surging Stocks That Don’t Need the AI Boom to Keep WinningJ.B. Hunt's Stock Plunges After Market Misprices Profit WarningLennar’s Earnings Miss May Be Sending a Bigger Warning About U.S. Housing3 Software Stocks Rebounding as AI Fears Give Way to Growth Upcoming Earnings Cintas (9/23/2026)Costco Wholesale (9/24/2026)Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
